Seems a bit of a contradiction to me; bully companies to reduce the cost of drugs - then bully them to make more of the drugs here which will likely make them more expensive.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.